share_log

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

為什麼 NLS 製藥業股票下跌了 66% 以上; 這是 68 從昨天開始的最大動力
Benzinga Real-time News ·  2022/09/29 05:11
Gainers
漲幅
PepGen Inc. (NASDAQ:PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint. Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares rose 103.8% to close at $9.58 after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint. Prothena Corporation plc (NASDAQ:PRTA) shares jumped 87.5% to close at $58.00 on Wednesday after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer's treatment candidate. Prothena is a biotechnology company that focuses on protein...
百事根股份有限公司 (納斯達克:PEPG)在公司宣布針對杜興肌營養不良症的 PGN-EDO51 第一階段健康志願者試驗結果之後,上漲了 110.2%,收於 10.93 美元。試驗符合其主要端點。 ...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論